Christopher J. Kratochvil

Learn More
OBJECTIVE Response to atomoxetine, a nonstimulant norepinephrine-specific reuptake inhibitor, was compared with the effect of osmotic-release oral methylphenidate, a long-acting methylphenidate(More)
Despite significant functional impairments associated with attention-deficit hyperactivity disorder (ADHD) and the growing appreciation of the importance of health-related quality of life (HRQL)(More)
Background: Recent reviews have argued that emotional impulsiveness (EI) and deficient emotional selfregulation are central components in attention-deficit/hyperactivity disorder (ADHD), not merely(More)
OBJECTIVE Numerous investigations have examined the efficacy of pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD) in children. However, relatively few studies have(More)